Identification of α-glucosidase inhibitors from Cortex Lycii based on a bioactivity-labeling high-resolution mass spectrometry-metabolomics investigation.

[1]  Awanish Kumar,et al.  Therapeutic molecules against type 2 diabetes: What we have and what are we expecting? , 2017, Pharmacological reports : PR.

[2]  D. Staerk,et al.  Facilitated Visual Interpretation of Scores in Principal Component Analysis by Bioactivity-Labeling of 1H-NMR Spectra—Metabolomics Investigation and Identification of a New α-Glucosidase Inhibitor in Radix Astragali , 2017, Molecules.

[3]  Joost T. van Dongen,et al.  Mass spectrometry-based plant metabolomics: Metabolite responses to abiotic stress. , 2016, Mass spectrometry reviews.

[4]  Keun Woo Lee,et al.  Cinnamic acid amides from Tribulus terrestris displaying uncompetitive α-glucosidase inhibition. , 2016, European journal of medicinal chemistry.

[5]  Usman Ghani.  Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. , 2015, European journal of medicinal chemistry.

[6]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[7]  L. Dragsted,et al.  Development of a bioassay-coupled HPLC-SPE-ttNMR platform for identification of α-glucosidase inhibitors in apple peel (Malus ×domestica Borkh.). , 2012, Food chemistry.

[8]  R. Bye,et al.  α-glucosidase inhibitors from Brickellia cavanillesii. , 2012, Journal of natural products.

[9]  P. Xiao,et al.  Phytochemical and Biological Studies of Lycium Medicinal Plants , 2011, Chemistry & biodiversity.

[10]  Y. Choi,et al.  Metabolomics for bioactivity assessment of natural products , 2011, Phytotherapy research : PTR.

[11]  Lian‐Wen Qi,et al.  Anti-diabetic agents from natural products--an update from 2004 to 2009. , 2010, Current topics in medicinal chemistry.

[12]  J. Schwabe,et al.  Structural basis for the activation of PPARγ by oxidized fatty acids , 2008, Nature Structural &Molecular Biology.

[13]  R. Witkamp,et al.  Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology , 2005, Phytotherapy research : PTR.

[14]  K. Hahm,et al.  Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense , 2004, Biotechnology Letters.

[15]  S. Yahara,et al.  Cyclic peptides, acyclic diterpene glycosides and other compounds from Lycium chinense Mill. , 1993, Chemical & pharmaceutical bulletin.

[16]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[17]  C. van Weel,et al.  Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. , 2005, Diabetes care.

[18]  M. Awazuhara,et al.  Plant Metabolomics: The Missing Link in Functional Genomics Strategies , 2002 .

[19]  S. Yahara,et al.  Structures of anti-ACE and -renin peptides from Lycii Radicis Cortex , 1989 .

[20]  Oral antidiabetic agents. , 1970, The Medical journal of Australia.